Subscribe via RSS

Tag: barclays capital

Equities
India's Tulip IT issues $125 million convertible
The offering comes after a four-fold increase in the company's share price in 12 months and marks the third Asian CB led by Barclays in a week.
By Anette Jönsson | 27 June 2007
People Moves
RBS hires SY Choi from Barclays
Choi will head the bank’s global banking and markets division in South Korea.
By Yi Tin Chak | 26 June 2007
People Moves
Barclays hires Sanjay Mathur from UBS
Mathur will assume a newly created role within the bank's Asia ex-Japan rates research team.
By Yi Tin Chak | 11 April 2007
Debt
Hana Bank prices successful benchmark bond
The Korean bank prices the largest Reg-S-only bank capital trade out of Asia.
By Rosie Slater | 4 April 2007
People Moves
Barclays builds on syndicated loan team
The bank announces three new hires as it forecasts a significant jump in the syndicated loan market.
By Andrew Peck | 5 December 2006
People Moves
Redward moves to Barclays in Singapore
The bank appoints a new head of rates research for emerging Asia.
By Andrew Peck | 7 November 2006
Debt
Kexim stumbles over the finish line
One of Asia’s most savvy borrowers misses the mark with its new dual-tranche bond deal.
By Timothy Cuffe | 29 September 2006
Debt
Shinhan prices second hybrid tier-1 deal
The Korean bank brings its first deal since winning the LG Card bid and becomes the first Asian bank to have multiple tier-1 transactions in the market.
By Timothy Cuffe | 14 September 2006
Debt
Hana wraps up new lower tier 2 deal
Barclays, BNP Paribas and Deutsche close most recent Korean bank capital transaction.
By Timothy Cuffe | 8 September 2006
Debt
ANZ launches A$1 billion collateralised loan obligation
Arrangers sound out investors in Hong Kong and Singapore before establishing a price bracket for the A$1 billion deal.
By Cherie Marriott | 31 August 2006
Debt
What's happened to Asian international bond issuance?
Confusing statements from the new Fed Chairman have forced Asia's international bond markets to go deathly quiet.
By Timothy Cuffe | 16 May 2006
Equities
Aurobindo Pharma CB uses rare premium structure
Strong expansion story allows company to fix conversion price on 25% of the deal in 12 months time; investors compensated by high yield and high bond floor.
By Anette Jönsson | 23 April 2006
« Prev | 1... | Next »
Tag Filters
MOST READ
Polls
How much value do investment banks bring to IPOs?
   |   View results
$$$$$
  15%
 
$$$
  21%
 
$
  64%
TOTAL VOTES: 92

 
View previous polls »
LATEST FROM AsianInvestor
Latest headlines from AsianInvestor
More from AsianInvestor »
WEBCASTS
On Demand Webcasts
View all webcasts »
Tables
Latest League Tables » Dealogic
DCM | ECM | M&A | Fees
Debt Pipeline »
Equity Pipeline »
Magazine
FinanceAsia Magazine
FinanceAsia
May 2012